Impact of Drug Policy on Regional Trends in Ezetimibe Use | Zendy

Lingyun Lu | Zendy; Harlan M. Krumholz | Zendy; Jack V. Tu | Zendy; Joseph S. Ross | Zendy; Dennis T. Ko | Zendy; Cynthia A. Jackevicius | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Drug Policy on Regional Trends in Ezetimibe Use

Author(s) -

Lingyun Lu,

Harlan M. Krumholz,

Jack V. Tu,

Joseph S. Ross,

Dennis T. Ko,

Cynthia A. Jackevicius

Publication year - 2014

Publication title -

circulation cardiovascular quality and outcomes

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.692

H-Index - 87

eISSN - 1941-7705

pISSN - 1941-7713

DOI - 10.1161/circoutcomes.114.001023

Subject(s) - ezetimibe , formulary , restrictiveness , population , medicine , demography , geography , environmental health , family medicine , linguistics , statin , philosophy , sociology

Ezetimibe use has steadily increased in Canada during the past decade even in the absence of evidence demonstrating a beneficial effect on clinical outcomes. Among the 4 most populated provinces in Canada, there is a gradient in the restrictiveness of ezetimibe in public-funded formularies (most to least strict: British Columbia, Alberta, Quebec, and Ontario). The effect of formulary policy on the use of ezetimibe over time is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research